P21 Both Attenuates and Drives Senescence and Aging in BubR1 Progeroid Mice

Cell Reports

Volumn 3, Issue 4, 2013, Pages 1164-1174

  Baker, DarrenJ ^a   Weaver, RobbynL ^a   VanDeursen, JanM ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUB1 RELATED PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FAT; PROTEIN P21; PROTEIN P53;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; EMBRYO; LENS EPITHELIUM; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROGERIA; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN TARGETING; SENESCENCE; SKELETAL MUSCLE; STEM CELL; TISSUE INJURY;

ADIPOSE TISSUE; ALLELES; ANIMALS; CATARACT; CELL AGING; CELL LINE; CHROMOSOME DISORDERS; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENOTYPE; LENS, CRYSTALLINE; LONGEVITY; MICE; MOSAICISM; MUSCLE, SKELETAL; PROTEIN-SERINE-THREONINE KINASES; STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 84876998223     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.028     Document Type: Article

References (48)

1. Babu J.R., Jeganathan K.B., Baker D.J., Wu X., Kang-Decker N., van Deursen J.M. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J.Cell Biol. 2003, 160:341-353.
2. Baker D.J., Jeganathan K.B., Cameron J.D., Thompson M., Juneja S., Kopecka A., Kumar R., Jenkins R.B., de Groen P.C., Roche P., van Deursen J.M. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat. Genet. 2004, 36:744-749.
3. Baker D.J., Jeganathan K.B., Malureanu L., Perez-Terzic C., Terzic A., van Deursen J.M. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J.Cell Biol. 2006, 172:529-540.
4. Baker D.J., Jin F., van Deursen J.M. The yin and yang of the Cdkn2a locus in senescence and aging. Cell Cycle 2008, 7:2795-2802.
5. Baker D.J., Perez-Terzic C., Jin F., Pitel K.S., Niederländer N.J., Jeganathan K., Yamada S., Reyes S., Rowe L., Hiddinga H.J., et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat. Cell Biol. 2008, 10:825-836.
6. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
7. Baker D.J., Dawlaty M.M., Wijshake T., Jeganathan K.B., Malureanu L., van Ree J.H., Crespo-Diaz R., Reyes S., Seaburg L., Shapiro V., et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat. Cell Biol. 2013, 1:96-102.
8. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377:552-557.
9. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: what is the connection?. Nat. Rev. Mol. Cell Biol. 2010, 11:567-578.
10. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
11. Cao L., Li W., Kim S., Brodie S.G., Deng C.X. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev. 2003, 17:201-213.
12. Cawthorn W.P., Scheller E.L., MacDougald O.A. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J.Lipid Res. 2012, 53:227-246.
13. Cheung T.H., Quach N.L., Charville G.W., Liu L., Park L., Edalati A., Yoo B., Hoang P., Rando T.A. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 2012, 482:524-528.
14. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 2007, 39:99-105.
15. Conboy I.M., Rando T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 2002, 3:397-409.
16. Conboy I.M., Conboy M.J., Smythe G.M., Rando T.A. Notch-mediated restoration of regenerative potential to aged muscle. Science 2003, 302:1575-1577.
17. el-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 1998, 8:345-357.
18. Feng Z., Hu W., Teresky A.K., Hernando E., Cordon-Cardo C., Levine A.J. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc. Natl. Acad. Sci. USA 2007, 104:16633-16638.
19. Gau P., Rodriguez S., De Leonardis C., Chen P., Lin D.M. Air-assisted intranasal instillation enhances adenoviral delivery to the olfactory epithelium and respiratory tract. Gene Ther. 2011, 18:432-436.
20. Hanks S., Coleman K., Reid S., Plaja A., Firth H., Fitzpatrick D., Kidd A., Méhes K., Nash R., Robin N., et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 2004, 36:1159-1161.
21. Hartman T.K., Wengenack T.M., Poduslo J.F., van Deursen J.M. Mutant mice with small amounts of BubR1 display accelerated age-related gliosis. Neurobiol. Aging 2007, 28:921-927.
22. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 1994, 4:1-7.
23. Joe A.W., Yi L., Natarajan A., Le Grand F., So L., Wang J., Rudnicki M.A., Rossi F.M. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 2010, 12:153-163.
24. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91:649-659.
25. Kasper L.H., Brindle P.K., Schnabel C.A., Pritchard C.E., Cleary M.L., van Deursen J.M. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol. Cell. Biol. 1999, 19:764-776.
26. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
27. Kirkwood T.B. p53 and ageing: too much of a good thing?. Bioessays 2002, 24:577-579.
28. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., Sharpless N.E. Ink4a/Arf expression is a biomarker of aging. J.Clin. Invest. 2004, 114:1299-1307.
29. Lane A.H., Aijaz N., Galvin-Parton P., Lanman J., Mangano R., Wilson T.A. Mosaic variegated aneuploidy with growth hormone deficiency and congenital heart defects. Am. J. Med. Genet. 2002, 110:273-277.
30. Lotz M.K., Caramés B. Autophagy and cartilage homeostasismechanisms in joint health, aging and OA. Nat. Rev. Rheumatol. 2011, 7:579-587.
31. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., Sutherland A., Thorner M., Scrable H. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004, 18:306-319.
32. Marion R.M., Strati K., Li H., Tejera A., Schoeftner S., Ortega S., Serrano M., Blasco M.A. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
33. Matheu A., Maraver A., Klatt P., Flores I., Garcia-Cao I., Borras C., Flores J.M., Viña J., Blasco M.A., Serrano M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 2007, 448:375-379.
34. Matsumoto T., Baker D.J., d'Uscio L.V., Mozammel G., Katusic Z.S., van Deursen J.M. Aging-associated vascular phenotype in mutant mice with low levels of BubR1. Stroke 2007, 38:1050-1056.
35. Matsuura S., Matsumoto Y., Morishima K., Izumi H., Matsumoto H., Ito E., Tsutsui K., Kobayashi J., Tauchi H., Kajiwara Y., et al. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am. J. Med. Genet. A. 2006, 140:358-367.
36. Minagawa S., Araya J., Numata T., Nojiri S., Hara H., Yumino Y., Kawaishi M., Odaka M., Morikawa T., Nishimura S.L., et al. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300:L391-L401.
37. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 2004, 95:7-11.
38. Núñez F., Chipchase M.D., Clarke A.R., Melton D.W. Nucleotide excision repair gene (ERCC1) deficiency causes G(2) arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21. FASEB J. 2000, 14:1073-1082.
39. Papazoglu C., Mills A.A. p53: at the crossroad between cancer and ageing. J.Pathol. 2007, 211:124-133.
40. Rio Frio T., Lavoie J., Hamel N., Geyer F.C., Kushner Y.B., Novak D.J., Wark L., Capelli C., Reis-Filho J.S., Mai S., et al. Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia. N.Engl. J. Med. 2010, 363:2628-2637.
41. Sharpless N.E. Ink4a/Arf links senescence and aging. Exp. Gerontol. 2004, 39:1751-1759.
42. Suijkerbuijk S.J., van Osch M.H., Bos F.L., Hanks S., Rahman N., Kops G.J. Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy. Cancer Res. 2010, 70:4891-4900.
43. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
44. Varela I., Cadiñanos J., Pendás A.M., Gutiérrez-Fernández A., Folgueras A.R., Sánchez L.M., Zhou Z., Rodríguez F.J., Stewart C.L., Vega J.A., et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 2005, 437:564-568.
45. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:275-283.
46. Vousden K.H., Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009, 137:413-431.
47. Wang C., Li Q., Redden D.T., Weindruch R., Allison D.B. Statistical methods for testing effects on "maximum lifespan". Mech. Ageing Dev. 2004, 125:629-632.
48. Wijshake T., Malureanu L.A., Baker D.J., Jeganathan K.B., van de Sluis B., van Deursen J.M. Reduced life- and healthspan in mice carrying a mono-allelic BubR1 MVA mutation. PLoS Genet. 2012, 8:e1003138.